Segersten U - Search Results

1

Increased 25-hydroxyvitamin D3 1alpha-hydroxylase and reduced 25-hydroxyvitamin D3 24-hydroxylase expression in parathyroid tumors--new prospects for treatment of hyperparathyroidism with vitamin d.

Correa P, Segersten U, Hellman P, Akerstrom G, Westin G. Correa P, et al. Among authors: segersten u. J Clin Endocrinol Metab. 2002 Dec;87(12):5826-9. doi: 10.1210/jc.2002-021356. J Clin Endocrinol Metab. 2002. PMID: 12466393

2

25-hydroxyvitamin D(3)-1alpha-hydroxylase expression in normal and pathological parathyroid glands.

Segersten U, Correa P, Hewison M, Hellman P, Dralle H, Carling T, Akerström G, Westin G. Segersten U, et al. J Clin Endocrinol Metab. 2002 Jun;87(6):2967-72. doi: 10.1210/jcem.87.6.8604. J Clin Endocrinol Metab. 2002. PMID: 12050281

3

Vitamin D3 polyunsaturated side-chain analogues (EB1089, GS1590) and the 20-epi-vitamin D3 analogue CB1393 suppress parathyroid hormone secretion and mRNA level in bovine parathyroid cells.

Segersten U, Holm PK, Binderup L, Akerström G, Hellman P, Westin G. Segersten U, et al. J Steroid Biochem Mol Biol. 2004 Mar;88(3):289-94. doi: 10.1016/j.jsbmb.2003.12.009. J Steroid Biochem Mol Biol. 2004. PMID: 15120422

4

Parathyroid glands in calcium regulation and human disease.

Akerström G, Hellman P, Hessman O, Segersten U, Westin G. Akerström G, et al. Among authors: segersten u. Ann N Y Acad Sci. 2005 Apr;1040:53-8. doi: 10.1196/annals.1327.005. Ann N Y Acad Sci. 2005. PMID: 15891005 Review.

5

25-Hydroxyvitamin D3 1alpha-hydroxylase expression in breast cancer and use of non-1alpha-hydroxylated vitamin D analogue.

Segersten U, Holm PK, Björklund P, Hessman O, Nordgren H, Binderup L, Akerström G, Hellman P, Westin G. Segersten U, et al. Breast Cancer Res. 2005;7(6):R980-6. doi: 10.1186/bcr1332. Epub 2005 Oct 6. Breast Cancer Res. 2005. PMID: 16280049 Free PMC article.

6

Potentiating effects of nonactive/active vitamin D analogues and ketoconazole in parathyroid cells.

Segersten U, Björklund P, Hellman P, Akerström G, Westin G. Segersten U, et al. Clin Endocrinol (Oxf). 2007 Mar;66(3):399-404. doi: 10.1111/j.1365-2265.2006.02746.x. Clin Endocrinol (Oxf). 2007. PMID: 17302875

7

An overview on preclinical and clinical experiences with photodynamic therapy for bladder cancer.

Yavari N, Andersson-Engels S, Segersten U, Malmstrom PU. Yavari N, et al. Among authors: segersten u. Can J Urol. 2011 Aug;18(4):5778-86. Can J Urol. 2011. PMID: 21854709 Review.

8

Tumour expression of bladder cancer-associated urinary proteins.

Lindén M, Segersten U, Runeson M, Wester K, Busch C, Pettersson U, Lind SB, Malmström PU. Lindén M, et al. Among authors: segersten u. BJU Int. 2013 Aug;112(3):407-15. doi: 10.1111/j.1464-410X.2012.11653.x. Epub 2013 Mar 7. BJU Int. 2013. PMID: 23470167

9

Choline-phosphate cytidylyltransferase-α as a possible predictor of survival and response to cisplatin neoadjuvant chemotherapy in urothelial cancer of the bladder.

Hemdan T, Turker P, Malmström PU, Segersten U. Hemdan T, et al. Among authors: segersten u. Scand J Urol. 2018 Jun;52(3):200-205. doi: 10.1080/21681805.2018.1439527. Epub 2018 Feb 23. Scand J Urol. 2018. PMID: 29475387 Free article.

10

Impact of thawing on RNA integrity and gene expression analysis in fresh frozen tissue.

Botling J, Edlund K, Segersten U, Tahmasebpoor S, Engström M, Sundström M, Malmström PU, Micke P. Botling J, et al. Among authors: segersten u. Diagn Mol Pathol. 2009 Mar;18(1):44-52. doi: 10.1097/PDM.0b013e3181857e92. Diagn Mol Pathol. 2009. PMID: 19214109

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

43 results

Search Page

Filters